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Abstract Celiac disease is caused by an abnormal intestinal
T-cell response to gluten proteins of wheat, barley and rye.
Over the last few years, a number of gluten T-cell epitopes
restricted by celiac disease associated HLA-DQ molecules
have been characterized. In this work, we give an overview




Celiac disease (CD) is caused by an abnormal intestinal
immune response to proline and glutamine-rich wheat glu-
ten proteins and to similar proteins in barley and rye (Green
and Cellier 2007). Oat is generally considered safe for
consumption by CD patients (Garsed and Scott 2007), al-
though some patients appear to be sensitive to oat as well
(Lundin et al. 2003). The only established treatment for the
disease is a lifelong gluten exclusion diet.
CD has a strong HLA association. The most prominent
association is with HLA-DQ2.5 (DQA1*05:01,
DQB1*02:01) (Table 1). In individuals who carry the
DR3DQ2 haplotype, this molecule is encoded by DQA1 and
DQB1 alleles located on the same chromosome (in cis config-
uration), whereas in individuals who are DR5DQ7/DR7DQ2
heterozygous it is encoded by alleles located on opposite
chromosomes (trans configuration) (Sollid et al. 1989). Most
of the remaining patients carry DR4DQ8 haplotypes, and in
these patients it is the DQ8 molecule encoded by DQA1*03,
DQB1*03:02 that is involved in the pathogenesis (Lundin et
al. 1994). In the small remaining population of CD patients
that are neither DQ2.5 or DQ8, the patients typically express
HLA-DQ molecules that contain ‘half’ of DQ2.5 molecule as
they areeither DQ2.2 (DQA1*02:01, DQB1*02:01) or DQ7.5
(DQA1*05, DQB1*03:01) (Karell et al. 2003). As both the
DQA1 and DQB1 loci are polymorphic, unique HLA-DQ
molecules can be encoded in trans configuration. Examples
of such molecules are DQ2.3 (DQA1*03, DQB1*02:01) and
DQ8.5 (DQA1*05, DQB1*03:02) found in DR3DQ2/
DR4DQ8 heterozygous individuals (Table 1).
CD4
+ T cells of CD patients (Lundin et al. 1993), but not
healthy subjects (Molberg et al. 1997), recognize gluten pep-
tides when presented by disease associated HLA-DQ mole-
cules. This was first shown for DQ2.5 and DQ8 (Lundin et al.
1994), and recently it was demonstrated that DQ2.2 patients
(Boddetal.2012)andapatientwhocarriesDQ8.5inararecis
configuration (Kooy-Winkelaar et al. 2011)a l s oh a v eg l u t e n -
reactive T cells in the intestinal mucosa. Gluten-reactive T
cells can readily be established from intestinal biopsies cul-
tured in vitro (Camarca et al. 2009; Lundin et al. 1993, 1994;
Tye-Din et al. 2010; Vader et al. 2002b;v a nd eW a le ta l .
1998b). T cells recognizing the same gluten epitopes are
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DOI 10.1007/s00251-012-0599-znormally not detected in the peripheral blood (Anderson et al.
2000), but can be found in the blood of treated CD patients on
day 6 after a 3-day oral gluten challenge (Anderson et al.
2000, 2005;R á k ie ta l .2007).
HLA is the most important genetic factor in CD, and
carriage of certain HLA alleles is a necessary, but not
sufficient, factor for disease development (Sollid 2002).
The other factors required for disease development are
non-HLA genes, of which 39 loci have been identified
so far (Trynka et al. 2011), and possibly environmental
factors other than gluten. To note, mice transgenic for
HLA-DQ2.5 and gluten specific T-cell receptors do not
develop a CD-like enteropathy (de Kauwe et al. 2009;
Du Pre et al. 2011). The reason why these mice do not
develop enteropathy may relate to fundamental differ-
ences in the gut physiology between mouse and man,
and to the lack of appropriate non-MHC genes in the
mouse strains tested that parallel the non-HLA suscep-
tibility genes of CD patients.
The differential risk of DQ2.5 and DQ2.2 is linked with
the T-cell response to gluten. It has been demonstrated that
DQ2.5 binds a larger gluten peptide repertoire compared to
DQ2.2 (Vader et al. 2003b). Further, gluten T-cell epitopes
form stable complexes with DQ2.5, and the increased risk of
DQ2.5 over DQ2.2 correlates with a different ability of the
two HLA molecules to form stable complexes with many
gluten peptides (Fallang et al. 2009).
Characteristically, gluten-reactive T cells of CD patients
recognize their antigenic peptides much better when specific
glutamine residues are converted to glutamate by the enzyme
transglutaminase 2 (TG2) (Molberg et al. 1998; van de Wal et
al. 1998a). Deamidated gluten peptides bind with increased
affinity to DQ2.5 and DQ8 (Arentz-Hansen et al. 2000;
Camarca et al. 2009; Henderson et al. 2007; Kim et al.
2004; Moustakas et al. 2000; Quarsten et al. 1999), and the
rateofdissociationofdeamidatedglutenpeptidesfromDQ2.5
has been shown tobe substantially slower thanfor their native
counterparts (Xia et al. 2005). The ability to form stable
peptide–MHC complexes again seems to be a key factor for
the initiation of the anti-gluten T-cell response.
Gluten is defined as the cohesive mass that remains
when dough is washed to remove starch (Shewry et al.
1992). Traditionally and strictly speaking, gluten is a
name of wheat proteins only, but gluten is now increas-
ingly used as a term to denote proline- and glutamine-
rich proteins of wheat, barley, rye and oat. In wheat,
gluten consists of the gliadin and glutenin subcompo-
nents. The gliadin proteins can be subdivided into α-,
γ-a n dω-gliadins, while the glutenin proteins can be
s u b d i v i d e di n t oh i g hm o l e c u l a rw e i g h t( H M W )a n dl o w
molecular weight (LMW) subunits. Common bread
wheat is a hexaploid species, and in addition some of
the gluten protein encoding genes originate from dupli-
cated loci. Thus, in a single wheat variety there exits up
to several hundred different gluten proteins, many of
which only differ by a few amino acids. The proline- and
glutamine-rich proteins of barley, rye and oat are termed
hordeins, secalins and avenins, respectively.
Given the heterogeneity of the wheat gluten proteins,
it is no surprise that many distinct gliadin and glutenin
derived T-cell epitopes exist (Table 2). T-cell epitopes
derived from either α-, γ-, and ω-gliadins as well as
from HMW and LMW glutenins have been reported
(Arentz-Hansen et al. 2000;S j ö s t r ö me ta l .1998; Vader
et al. 2002b;v a nd eW a le ta l .1998b). T-cell epitopes
in both hordeins and secalins have been described and
they are highly homologous to those found in wheat
(Tye-Din et al. 2010; Vader et al. 2003a). The avenins
of oat are more distinct, and although oat is considered
safe for CD patients (Garsed and Scott 2007), some CD
patients are clinically sensitive to oat (Lundin et al.
2003). Avenin specific as well as cross-reactive responses
have been described (Arentz-Hansen et al. 2004; Vader et al.
2003a).
There is at present no standard nomenclature for CD-
relevant gluten epitopes. Here, we propose such a nomen-
clature based on the following three criteria:
1. Reactivity against the epitope must have been defined
by at least one specific T-cell clone.
Table 1 Description and nam-
ing of HLA-DQ molecules that
are associated with celiac disease
and which are used as antigen
presenting elements for CD4
+ T
cells of celiac disease patients
aRisk for celiac disease has not
been established in population
studies
bMolecule can also be encoded
in cis on some rare haplotypes






HLA-DQ molecule DQA1* DQB1*
HLA-DQ2.5 05 02 High cis, trans DR3DQ2
HLA-DQ2.2 02 02 Low cis, (trans) DR7DQ2
HLA-DQ2.3 03 02 Likely low
a trans, (cis)
b
HLA-DQ7.5 05 03:01 Very low cis, (trans) DR5DQ7
HLA-DQ8 03 03:02 Low cis DR4DQ8
HLA-DQ8.5 05 03:02 Likely low
a trans, (cis)
b
456 Immunogenetics (2012) 64:455–4602. The HLA-restriction element involved must have been
unequivocally defined.
3. The nine-amino acid core of the epitope must have been
defined either by an analysis with truncated peptides
and/or HLA-binding with lysine scan of the epitope or
comparable approach.
Searching the literature using these criteria, we have
compiled a list of epitopes (Table 2). This list includes
sequences from α-gliadin, γ-gliadin, ω-gliadin, LMW-
and HMW-glutenins, hordeins, secalins and avenins. To
note, most gluten-reactive T cells have minimal epitopes
longer than those listed in Table 2. This is because MHC
Table 2 List of celiac disease relevant T-cell epitopes recognized by CD4
+ T cells
Epitope




DQ2.5-glia-α1a DQ2-α-I, α9 PFPQPE L P Y (Arentz-Hansen et al. 2000)
DQ2.5-glia-α1b DQ2-α-III P Y P Q P E L P Y (Arentz-Hansen et al. 2002)
DQ2.5-glia-α2 DQ2-α-II, α2P Q P E L P Y P Q (Arentz-Hansen et al. 2000)
DQ2.5-glia-α3 glia-α20 F R P E Q P Y P Q (Vader et al. 2002b)
DQ2.5-glia-γ1 DQ2-γ- I PQQSFPE Q Q (Sjöström et al. 1998)
DQ2.5-glia-γ2 DQ2-γ-II, γ30 I Q P E Q P A Q L (Qiao et al. 2005; Vader et al. 2002b)
DQ2.5-glia-γ3 DQ2-γ-III QQPE QPYPQ (Arentz-Hansen et al. 2002)
DQ2.5-glia-γ4a DQ2-γ-IV S Q P E Q E F P Q (Arentz-Hansen et al. 2002)
DQ2.5-glia-γ4b DQ2-γ-VIIc P Q P E Q E F P Q (Qiao et al. 2005)
DQ2.5-glia-γ4c DQ2-γ-VIIa QQPE Q P F P Q (Arentz-Hansen et al. 2002)
DQ2.5-glia-γ4d DQ2-γ-VIIb P Q P E QPFCQ (Qiao, unpublished)
DQ2.5-glia-γ5 DQ2-γ-VI Q Q P F P E Q P Q (Arentz-Hansen et al. 2002)
DQ2.5-glia-ω1 DQ2-ω- I PFPQPE Q P F (Tye-Din et al. 2010)
DQ2.5-glia-ω2 DQ2-ω-II P Q P E Q P F P W (Tye-Din et al. 2010)
DQ2.5-glut-L1 glutenin-17 P F S E Q E Q P V (Vader et al. 2002b)
DQ2.5-glut-L2 glutenin-156 F S QQQE S P F (Stepniak et al. 2005; Vader et al. 2002b)
DQ2.5-hor-1 Hor-α9, Hα9 PFPQPE Q P F (Tye-Din et al. 2010; Vader et al. 2003a)
DQ2.5-hor-2 Hor-α2, Hα2P Q P E Q P F P Q (Vader et al. 2003a)
DQ2.5-hor-3 hor-I-DQ2 P I P E Q P Q P Y (Tye-Din et al. 2010)
DQ2.5-sec-1 Sec-α9, Sα9 PFPQPE Q P F (Tye-Din et al. 2010; Vader et al. 2003a)
DQ2.5-sec-2 Sec-α2, Sα2P Q P E Q P F P Q (Vader et al. 2003a)
DQ2.5-ave-1a Av-α9A P Y P E Q E E P F (Arentz-Hansen et al. 2004; Vader et al. 2003a)
DQ2.5-ave-1b Av-α9B, 1490 P Y P E Q E Q P F (Arentz-Hansen et al. 2004; Vader et al. 2003a)
DQ2.2 restricted epitopes
DQ2.2-glut-L1 glutenin-17 P F S E Q E Q P V (Bodd et al. 2012)
DQ8 restricted epitopes
DQ8-glia-α1 DQ8-α-I E GSFQPSQE (van de Wal et al. 1998b)
DQ8-glia-γ1a DQ8-γ-Ia E QPQ Q P F P Q (Tollefsen et al. 2006)
DQ8-glia-γ1b DQ8-γ-Ib E QPQQPYPE (Tollefsen et al. 2006)
DQ8-glut-H1 HMW-glutenin QGYYPTSPQ (van de Wal et al. 1999)
DQ8.5 restricted epitopes
DQ8.5-glia-α1 DQ8-α-I E GSFQPSQE (Kooy-Winkelaar et al. 2011)
DQ8.5-glia-γ1 PQQSFPE Q E (Kooy-Winkelaar et al. 2011)
DQ8.5-glut-H1 HMW-glutenin QGYYPTSPQ (Kooy-Winkelaar et al. 2011)
aIn the epitope names, these short terms are used to denote the type of proteins that the epitopes derive from: ‘glia-α’ denotes α-gliadin, ‘glia-γ’
denotes γ-gliadin, ‘glia-ω’ denotes ω-gliadin, ‘glut-L’ denotes low molecular weight glutenin, ‘glut-H’ denotes high molecular weight glutenin,
‘hor’ denotes hordein, ‘sec’ denotes secalin and ‘ave’ denotes avenin
bGlutamate residues (E) formed by TG2-medited deamidation which are important for recognition by T cells are shown in bold. Additional
glutamine residues also targeted by TG2 are underlined
Immunogenetics (2012) 64:455–460 457class II restricted T-cell receptors usually are sensitive to a
few residues flanking the nine-amino acid core region of the
epitopes.
In Table 2, some sequences that previously were defined
as individual epitopes have been grouped together as mem-
bers of the same family. This pertains to the DQ2.5-glia-α1a
and DQ2.5-glia-α1b as well as the DQ2.5-glia-γ4a, DQ2.5-
glia-γ4b, DQ2.5-glia-γ4c and DQ2.5-glia-γ4d epitopes.
The reason is that the sequences defining these epitopes
are very similar, although there are occasionally T-cell
clones that can distinguish between members of the same
epitope family (Arentz-Hansen et al. 2002;Q i a oe ta l .
2005). Most T-cell clones appear to cross-react between
peptide sequences of the same family.
The nine-amino acid core sequences of some of the DQ2.5
restricted epitopes are identical, but because these epitopes
derive from different cereal species they are still listed as
unique epitopes. This applies to the DQ2.5-glia-ω1, DQ2.5-
hor-1 and DQ2.5-sec-1 epitopes, as well as DQ2.5-hor-2 and
DQ2.5-sec-2epitopes.T-cellcross-reactivitybetweenproteins
ofdifferentspecieshencedoesoftenoccur,butTcellsreactive
with these epitopes can also be species-specific as the T-cell
receptors may be sensitive to unique residues flanking the
nine-amino acid core region of the epitopes. In addition, there
areepitopes,likeDQ2.5-hor-3(Tye-Dinetal.2010),thathave
sequences which are hordein or secalin specific and which
elicit species specific T-cell responses.
The majority of gluten-reactive T cells generated from
DQ2.5 positive CD patients can recognize their epitopes when
confronted in vitro with antigen presenting cells expressing the
closely related HLA-DQ2.2 molecule (DQA1*02:01,
DQB1*02:01). Yet, DQ2.2 positive CD patients do not
mount a T-cell response to the same gluten epitopes,
but rather have responses to gluten peptides that bind stably
to DQ2.2 (Bodd et al. 2012). When defining an epitope, it is
thus important to assess and categorize the epitope only in the
context of the HLA molecules that are expressed by the T-cell
donor.
The selection of gluten T-cell epitopes is best understood
in HLA-DQ2.5 positive CD patients, and is influenced by at
least three factors: (a) resistance of the polypeptide sequence
to proteolytic degradation, (b) specificity of TG2 and (c)
HLA binding specificity. The proline-rich nature of gluten
makes the gluten proteins resistant to proteolytic degrada-
tion in the gastrointestinal lumen, and long gluten peptide
fragments ranging from 15 to 50 residues therefore survive
in the small intestine (Shan et al. 2002). T-cell epitopes are
often localized within such long fragments (Arentz-Hansen
et al. 2002). The resulting proline and glutamine rich pep-
tides are often good substrates for TG2 (Dørum et al. 2009,
2010; Fleckenstein et al. 2002; Vader et al. 2002a). Proline
is influencing the specificity of TG2 as the enzyme typically
recognizes glutamine residues in glutamine-X-proline
sequences (Fleckenstein et al. 2002; Vader et al. 2002a).
T-cell epitopes in their native form are usually very good
substrates for TG2. TG2, being an important factor in the
selection of T-cell epitopes, is demonstrated by the fact that
TG2 is selectively targeting peptides which harbor T-cell
epitopes from a digest of gluten with extreme complexity
(Dørum et al. 2010). Finally, determinant selection by
MHC is influencing repertoire of T-cell epitopes. In
general, gluten peptides are poor binders to HLA class
II molecules with the exception of HLA-DQ molecules
associated with CD (Bergseng et al. 2008). Some gluten
peptides also bind HLA-DR53 (Clot et al. 1999), although so
far no Tcells of celiac lesions recognizing these peptides have
been described. The selective force of HLA is illustrated by
the observation that the DQ2.5 and DQ8 epitopes generally
come from non-overlapping sequences of gluten proteins
(Tollefsen et al. 2006).
The glutamate introduced by TG2 is usually in position 4
(P4), P6 or P7 in HLA-DQ2.5 restricted epitopes and at
position P1 and/or P9 in HLA-DQ8 restricted epitopes
(Table 2). These glutamate residues serve as anchor residues
important for binding of the peptides. Both HLA-DQ2.5 and
DQ8 prefer negatively charged residues at these anchors
sites. This positioning of deamidated glutamine residues is
strongly related to the positioning of proline residues, which
is particularly strict in the case of DQ2.5 epitopes, as DQ2.5
only accepts proline at certain position in the peptide bind-
ing groove (Kim et al. 2004). This results in a dominant
presence of proline at P1, P6 and P8 and leads to the
modification by TG2 of the glutamine residues at P4 and
P6, respectively. Such positioning of proline residues is less
strict in the case of the DQ8 epitopes. Although polyclonal
T-cell responses to multiple T-cell epitopes are almost inva-
riably found in CD patients, responses to the DQ2.5-glia-
α1a, DQ2.5-glia-α1b, DQ2.5-glia-α2 epitopes, DQ2.5-glia-
ω1, DQ2.5-glia-ω2, DQ2.5-hor-1 and DQ2-sec-1 are dom-
inant in DQ2.5 positive patients (Arentz-Hansen et al. 2000;
Camarca et al. 2009; Tollefsen et al. 2006; Tye-Din et al.
2010). In DQ8-positive patients, responses to the DQ8-glia-
α1 epitope are most frequently found (Tollefsen et al. 2006;
van de Wal et al. 1998b).
The list of gluten epitopes recognized by T cells of CD
patients presented in Table 2 will be extended as new
epitopes become known in the future. A dedicated website
(http://www.isscd.org/EpitopeNomenclature) will update
this list as more epitopes are identified.
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